¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"COM"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
  • JrId: 22861
    JournalTitle: Computer graphics.
    MedAbbr: Comput Graph (ACM)
    ISSN: 0097-8930
    ESSN:
    IsoAbbr:
    NlmId: 9879401
  • JrId: 22876
    JournalTitle: Comptes rendus de l'Academie des sciences. Serie II, Mecanique, physique, chimie, sciences de l'univers, sciences de la terre.
    MedAbbr: C R Acad Sci II
    ISSN: 0764-4450
    ESSN:
    IsoAbbr:
    NlmId: 9881439
  • JrId: 22893
    JournalTitle: Complicated Cardiac Patient.
    MedAbbr: Complicat Card Patient
    ISSN: 0888-3777
    ESSN:
    IsoAbbr:
    NlmId: 9883043
  • JrId: 22906
    JournalTitle: CVIU.
    MedAbbr: Comput Vis Image Underst
    ISSN: 1077-3142
    ESSN:
    IsoAbbr:
    NlmId: 9889342
  • JrId: 22909
    JournalTitle: Computers & graphics.
    MedAbbr: Comput Graph
    ISSN: 0097-8493
    ESSN:
    IsoAbbr:
    NlmId: 9889995
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • composite graft
    º¹ÇÕÀ̽Ä, º¹ÇÕÁ¶Á÷À̽Ä
  • composite index
    ÇÕ¼ºÁö¼ö
  • composite nucleolus
    º¹ÇÕÇÙ¼Òü
  • composite odontoma
    º¹ÇÕÄ¡¾ÆÁ¾
  • composite plasmid
    º¹ÇÕÇö󽺹̵å
  • composite scalp grafting
    µÎÇǺ¹ÇÕÀ̽Ä(¼ú)
  • composition defect
    ±¸¼º°áÇÔ
  • compound
    1. È­ÇÕ¹° 2. º¹ÇÕ
  • compound astigmatism
    º¹ÇÕ³­½Ã
  • compound dislocation
    º¹ÀâÅ»±¸
  • compound fracture
    º¹ÇÕ°ñÀý, °³¹æ°ñÀý
  • compound gland
    º¹ÇÕ»ù, º¹ÇÕ¼±
  • compound heterozygote
    º¹ÇÕÀÌÇüÁ¢ÇÕÀÚ
  • compound joint
    º¹ÇÕ°üÀý
  • compound lens
    º¹ÇÕ·»Áî
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • complete cervical contracture
    ¿ÏÀü¸ñ±¸Ãà ¿ÏÀü¸ñ±¸Ãà
  • complete crown
    (¢¡full crown) ÀüºÎ°ü, ¿ÏÀüµ¡´ïÄ¡¾Æ°ü
  • complete cure
    ¿ÏÀüÄ¡·á
  • complete denture
    ¿ÏÀüƲ´Ï, ¿ÏÀüÀÇÄ¡
  • complete dislocation
    ¿ÏÀüÅ»±¸
  • complete fracture
    ¿ÏÀü°ñÀý
  • complete hernia
    ¿ÏÀüÇ츣´Ï¾Æ
  • complete interference pattern
    ¿ÏÀü°£¼·¾ç»ó
  • complete life table
    ¿ÏÀü»ý¸íÇ¥
  • complete recruitment pattern
    ¿ÏÀüÁ¡Áõ¾ç»ó
  • complete retention
    ¿ÏÀüÀÜ·ù
  • complete segmentation
    ¿ÏÀüºÐÇÒ
  • complete situs inversus
    ÀüüÀÚ¸®¹Ù²Þ, ¿ÏÀü³»À忪À§
  • complete veneer crown
    ÀüºÎÇǺ¹°ü
  • completion
    À̼ö, ¿Ï¼ö, ¿Ï¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • common vehicle
    °øÅë¸Å°³Ã¼(˭̬ËÎ˧̧).
  • common vehicle spread
    °øÅë¸Åü¼º ÀüÆÄ(ÊÙËøÌ¬).
  • common ventricle
    °øÅë½É½Ç, ´Ü½É½Ç(Ó¤ãýãø).
  • common wart<³ª> verrucae vulgaris
    ½É»ó¼º(ãüßÈàõ) »ç¸¶±Í.
  • common wart<³ª> verrucae vulgaris
    ½É»ó¼º(ãüßÈàõ) »ç¸¶±Í
  • common warts
  • commotio =commotion<³ª>
    ÁøÅÁ(Áõ) (òè ñø).
  • commotio cerebri (³ª)
    ³úÁøÅÁ
  • commotio cerebri =commotion of brain<³ª>
    ³ú°ú ³úÁøÅÁ(Òàòè ).
  • commotio labyrinthi <³ª>
    ¹Ì·ÎÁøÅÁ(Áõ)
  • commotio labyrinthi<³ª>
    ¹Ì·ÎÁøÅÁ(Áõ)(Ú»ÖØòè ñø).
  • commotio retinae<³ª>
    ¸Á¸·ÁøÅÁ(Áõ)(ØÑدòè ñø).
  • commotio spinalis =spinal commotion<³ª>
    ô¼öÁøÅÁ(Áõ)(ô±âÐòè ñø).
  • commotion of heart<³ª> commotio cordis
    ½ÉÀåÁøÅÁ(Áõ)(ãýíôòè ñø).
  • commotion of thorax<³ª> commotio thoracis
    ÈäºÎÁøÅÁ(Áõ)(ýØÝ»òè ñø).
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
competition <zoology> A type of organism interaction which can be either between members of the same species or members of different species.
The relationship occurs when commodities (like food, mates, shelters, etc.) are scarce and there are not enough to go around for all members which need them. In general, all involved members of the relationship are harmed by this interaction.
(05 Jan 1998)
competition hybridisation <molecular biology, technique> A lab technique used to determine how similar two strands of single-stranded nucleic acids are to each other by putting them with a third strand (called a standard) and observing how well they can bond with each other to become double-stranded (how well they hybridize).
(05 Jan 1998)
competitive antagonist An antimetabolite.
(05 Mar 2000)
competitive behaviour The direct struggle between individuals for environmental necessities or for a common goal.
(12 Dec 1998)
competitive bidding Pricing statements presented by more than one party for the purpose of securing a contract.
(12 Dec 1998)
competitive binding assay General term for an assay in which a binder competes for labelled versus unlabelled ligand; following separation of free and bound ligand, the ligand (the analyte assayed) is quantitated by relating bound and unbound ratios to known standards.
See: enzyme-linked immunosorbent assay, radioreceptor assay, immunoassay, enzyme-multiplied immunoassay technique, radioimmunoassay.
Synonym: displacement analysis, saturation analysis.
(05 Mar 2000)
competitive inhibition <chemistry> Inhibitor that occupies the active site of an enzyme or the binding site of a receptor and prevents the normal substrate or ligand from binding.
at sufficiently high concentration of the normal ligand inhibition is lost: the Km is altered by the competitive inhibitor, but the Vmax remains the same.
(05 Jan 1998)
competitive medical plans Alternative health care delivery mechanisms, such as preferred provider organizations or other health insurance services or prepaid plans (other than health maintenance organizations), that meet medicare qualifications for a risk-sharing contract.
(12 Dec 1998)
competitor DNA DNA from a test organism that is denatured and then used in in vitro hybridization experiments in which it competes with DNA (homologous) from a reference organism; used to determine the relationship of the test organism to the reference organism.
(05 Mar 2000)
complaint A disorder, disease, or symptom, or the description of it.
Origin: O. Fr. Complainte, fr. L. Complango, to lament
(05 Mar 2000)
complement <immunology> A term originally used to refer to the heat labile factor in serum that causes immune cytolysis, the lysis of antibody coated cells and now referring to the entire functionally related system comprising at least 20 distinct serum proteins that is the effector not only of immune cytolysis but also of other biologic functions.
Complement activation occurs by two different sequences, the classic and alternative pathways. The proteins of the classic pathway are termed components of complement and are designated by the symbols C1 through C9.
C1 is a calcium dependent complex of three distinct proteins C1q, C1r and C1s. The proteins of the alternative pathway (collectively referred to as the properdin system) and complement regulatory proteins are known by semisystematic or trivial names. Fragments resulting from proteolytic cleavage of complement proteins are designated with lower case letter suffixes, for example, C3a. Inactivated fragments may be designated with the suffix i, for example C3bi. Activated components or complexes with biological activity are designated by a bar over the symbol for example C1 or C4b, 2a.
The classic pathway is activated by the binding of C1 to classic pathway activators, primarily antigen-antibody complexes containing IgM, IgG1, IgG3, C1q binds to a single IgM molecule or two adjacent IgG molecules.
The alternative pathway can be activated by IgA immune complexes and also by nonimmunologic materials including bacterial endotoxins, microbial polysaccharides and cell walls. Activation of the classic pathway triggers an enzymatic cascade involving C1, C4, C2 and C3, activation of the alternative pathway triggers a cascade involving C3 and factors B, D and P. Both result in the cleavage of C5 and the formation of the membrane attack complex.
Complement activation also results in the formation of many biologically active complement fragments that act as anaphylatoxins, opsonins or chemotactic factors.
(05 Jan 1998)
complement 1 The first complement component to act in the cytolysis reaction. It is a trimolecular complex held together with ca ions and when activated, has esterase activity which initiates the next step in the sequence.
(12 Dec 1998)
complement 1 inactivators Compounds which inhibit, antagonise, or inactivate complement 1. A well-known inhibitor is a serum glycoprotein believed to be alpha-2-neuroaminoglycoprotein. It inhibits the activated (esterase) form of complement 1 as well as kinin-forming, coagulation, and fibrinolytic systems. Deficiency of this inactivator has been found in patients with hereditary angioneurotic oedema. These compounds are members of the serpin superfamily.
(12 Dec 1998)
complement 1q <chemical> Subcomponent of complement 1 (c1) which recognises and binds to the heavy chain of IgG or IgM initiating the classical complement pathway. The interaction of c1q and immunoglobulin activates c1r and c1s. The activated c1r and c1s molecules are cleaved off the complex by c1-inhibitor, allowing the collagen-like region of c1q to become accessible for interaction with cell membrane c1q receptors.
Chemical name: Complement C1q
(12 Dec 1998)
complement 1r <enzyme> Subcomponent of complement 1 which, when activated by c1q, activates subcomponent c1s by proteolytic cleavage.
Registry number: EC 3.4.21.41
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 19
  • Complement C4b - »õâ The large fragment formed when COMPLEMENT C4 is cleaved by COMPLEMENT C1S. The membrane-bound C4b binds COMPLEMENT C2A, a SERINE PROTEASE, to form C4b2a (CLASSICAL PATHWAY C3 CONVERTASE) and subsequent C4b2a3b (CLASSICAL PATHWAY C5 CONVERTASE).
    Synonyms : C4b Complement, Complement 4b, Complement Component 4b, C4b, Complement, Complement, C4b, Component 4b, Complement
  • Complement C4b-Binding Protein - »õâ A serum protein that regulates the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It binds as a cofactor to COMPLEMENT FACTOR I which then hydrolyzes the COMPLEMENT C4B in the CLASSICAL PATHWAY C3 CONVERTASE (C4bC2a).
    Synonyms : C4b-Binding Protein, C4b-C3b Inactivator Cofactor, C4bC3bINA-Cofactor, Complement 4b Binding Protein, Complement C3b-C4b Inactivator Cofactor, Complement Component 4b-Binding Protein, C4b Binding Protein, C4b C3b Inactivator Cofactor, C4bC3bINA Cofactor
  • Complement C5 - »õâ C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX.
    Synonyms : C5 Complement, Complement 5, Complement C5, Precursor, Complement Component 5, Precursor C5, Pro-C5, Pro-complement 5, C5, Complement, C5, Precursor, C5, Precursor Complement, Complement, C5, Component 5, Complement, Precursor Complement C5, Pro C5, Pro complement 5
  • Complement C5 Convertase, Alternative Pathway - »õâ A serine protease that cleaves multiple COMPLEMENT C5 into COMPLEMENT C5A (anaphylatoxin) and COMPLEMENT C5B in the ALTERNATIVE COMPLEMENT ACTIVATION PATHWAY. It is the complex of ALTERNATIVE PATHWAY C3 CONVERTASE (C3bBb) with an additional COMPLEMENT C3B, or C3bBb3b.
    Synonyms : Alternative Pathway C5 Convertase, C5 Convertase (C3bBb3b), C5 Convertase, Alternative Pathway
  • Complement C5 Convertase, Classical Pathway - »õâ A serine protease that cleaves multiple COMPLEMENT 5 into COMPLEMENT 5A (anaphylatoxin) and COMPLEMENT 5B in the CLASSICAL COMPLEMENT ACTIVATION PATHWAY. It is a complex of CLASSICAL PATHWAY C3 CONVERTASE (C4b2a) with an additional COMPLEMENT C3B, or C4b2a3b.
    Synonyms : C5 Convertase (C4b2a3b), Classical C5 Convertase, Classical Pathway C5 Convertase, C5 Convertase, Classical
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 4 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
compression compaction: an increase in the density of something the process or result of becoming smaller or pressed together; "the contraction of a gas on cooling" encoding information while reducing the bandwidth or bits required applying pressure
Ãâó: wordnet.princeton.edu/perl/webwn
common iliac artery terminal branches of the abdominal aorta
Ãâó: wordnet.princeton.edu/perl/webwn
common iliac vein formed by the internal and external iliac veins; unites with its fellow from the opposite side of the body to form the inferior vena cava
Ãâó: wordnet.princeton.edu/perl/webwn
common cold cold: a mild viral infection involving the nose and respiratory passages (but not the lungs); "will they never find a cure for the common cold?"
Ãâó: wordnet.princeton.edu/perl/webwn
compression fracture one produced by compression, as of a vertebra; see also axial compression f.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • commercialization
    »ó¾÷(¿µ¸®,»óǰ)È­
  • commercialize
    À» »ó¾÷È­ÇÏ´Ù
  • commercialize
    »ó¾÷(¿µ¸®)È­ ÇÏ´Ù;»óǰȭÇÏ´Ù
  • commercially
    »ó¾÷ÀûÀ¸·Î
  • commercially
    »ó¾÷ÀûÀ¸·Î;¿µ¸®ÀûÀ¸·Î(º¸¾Æ);Åë»ó»ó
  • commerciogenic
    Àå»çÀ§ÁÖÀÇ;»ó¾÷ÀûÀ¸·Î ÀαâÀÖ´Â
  • commfu
    complete monumental military fuck-up ¿ÏÀüÇÑ ±º»çÀû ½ÇÆÐ
  • commie
    °ø»ê´ç¿ø
  • commie,-my
    °ø±êµ¹;°ø»ê´ç¿ø;»¡°»ÀÌ
  • comminate
    À§ÇùÇÏ´Ù;ÀúÁÖÇÏ´Ù
  • commination
    À§Çù;½Å¹úÀÇ ¼±¾ð
  • comminatory
    À§ÇùÀûÀÎ
  • commingle
    À» ¼¯´Ù
  • commingle
    È¥ÇÕÇÏ´Ù;µÚ¼¯ÀÌ´Ù
  • comminute
    °ö°Ô »¨´Ù;(ÅäÁöµîÀ»)¼¼ºÐÇÏ´Ù;ºÐ¼âÇÑ;¼¼ºÐÇÑ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 19
COM return to consciousness
COM cause to experience suddenly
COM attain
COM be about
COM deal with (a problem or a subject)
COM be revealed or disclosed
COM be born or come into existence
COM be lifelike
COM be revealed or disclosed
COM be remembered
COM make oneself visible
COM come together, as if in an embrace
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 19
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á